When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Common toxic plant ingestions

Evidence last reviewed: 21 Mar 2026
Topic last updated: 10 Apr 2024

Summary

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • tachycardia
  • hypertension
  • hypotension
  • miosis
  • mydriasis
  • bradycardia
  • altered mental state
  • hallucinations
  • seizures
Todos los datos

Otros factores de diagnóstico

  • nausea
  • vomiting
  • abdominal pain
  • diarrhea
  • dyspnea
  • skin flushing
  • dermatitis
  • dermatologic/mucosal irritation
  • visible bleeding: epistaxis, melena, hematuria, hematemesis, hemoptysis
  • headache
  • chest pain
  • muscle pain/swelling
  • skin pallor
  • easy bruising
  • petechial spotting
  • jaundice
  • asterixis
  • ascites
  • palmar erythema
  • spider angiomata
  • diaphoresis
  • dry skin
  • fever
  • urinary retention
  • constipation
  • hyperventilation
  • fasciculations
  • neuromuscular weakness
  • altered sensation
Todos los datos

Factores de riesgo

  • foraging for wild plants to eat
  • brewing wild plants into tea
  • children found or suspected of ingesting plants
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • ECG
  • CBC
  • serum electrolytes
  • serum creatinine
  • serum lactate
  • serum BUN/creatinine ratio
  • liver function tests
  • INR
  • ABG
  • chest x-ray
Todos los datos

Pruebas diagnósticas que deben considerarse

  • troponin
  • serum digoxin levels
  • response to physostigmine
Todos los datos

Algoritmo de tratamiento

Agudo

all patients

Colaboradores

Autores

Susan Smolinske, PharmD, DABAT, FAACT

Clinical Consultant

New Mexico Poison and Drug Information Center

Adjunct Professor

Pharmacy Practice and Administrative Sciences

University of New Mexico

Albuquerque

NM

Divulgaciones

SS is a member of the ToxED advisory board and consults with webPOISONCONTROL.

Cynthia K. Aaron, MD

Medical Director

Program Director Medical Toxicology

Regional Poison Center at Children's Hospital of Michigan

Professor of Emergency Medicine and Pediatrics

Wayne State University School of Medicine

Detroit

MI

Divulgaciones

CKA owns personal stock in Merck. CKA was on the State of Michigan Public Health Advisory Council for 3 years, and consults with RubiconMD.

Agradecimientos

Dr Susan Smolinske and Dr Cynthia K. Aaron would like to gratefully acknowledge Dr Gerald F. O'Malley and Dr Rika N. O'Malley, previous contributors to this topic.

Divulgaciones

GFOM and RNOM declare that they have no competing interests.

Revisores por pares

Jessamine Soderstrom, MD, MBBS, FACEM

Clinical Toxicologist

Emergency Consultant

Emergency Department

Royal Perth Hospital

Perth

Australia

Divulgaciones

JS declares that she has no competing interests.

Scott Phillips, MD

Clinical Faculty

Department of Toxicology

Rocky Mountain Poison & Drug Center

Denver

CO

Divulgaciones

SP declares that he has no competing interests.

Judith Alsop, PharmD, DABAT

Poison Center Director

California Poison Control System, Sacramento Division

University of California Davis Medical Center

Sacramento

Associate Clinical Professor of Pharmacy

University of California San Francisco School of Pharmacy

San Francisco

Clinical Professor of Medicine

Volunteer Clinical Faculty

University of California Davis School of Medicine

Sacramento

CA

Divulgaciones

JA declares that she has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Froberg B, Ibrahim D, Furbee RB. Plant poisoning. Emerg Med Clin North Am. 2007 May;25(2):375-433. Resumen

Gummin DD, Mowry JB, Beuhler MC, et al. 2022 Annual report of the National Poison Data System(®) (NPDS) from America's Poison Centers(®): 40th annual report. Clin Toxicol (Phila). 2023 Oct;61(10):717-939.Texto completo  Resumen

Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther. 2004 May;102(2):131-8. Resumen

Gowdy JM. Stramonium intoxication: review of symptomatology in 212 cases. JAMA. 1972 Aug 7;221(6):585-7. Resumen

Burkhard PR, Burkhardt K, Haenggeli CA, et al. Plant-induced seizures: reappearance of an old problem. J Neurol. 1999 Aug;246(8):667-70. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad